PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Apr-2023 Douglas GmbH: Fitch upgrades DOUGLAS‘ outlook to stable, affirms rating Douglas GmbH
12-Apr-2023 Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care Roche
12-Apr-2023 HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023 HUTCHMED
12-Apr-2023 Superpower or Clark Kent: what is the future for UK life sciences? Snedden Campbell
12-Apr-2023 Availability of Preparatory Documents for the Combined General Meeting on May 5, 2023 Transgene
12-Apr-2023 Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever Marinomed Biotech AG
12-Apr-2023 APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential APONTIS PHARMA AG
12-Apr-2023 Cantourage Group SE: Strong revenue growth in 2022 and Q1 2023 based on preliminary figures Cantourage Group SE
12-Apr-2023 Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023 Zur Rose Group AG
11-Apr-2023 Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD Nuance Pharma
11-Apr-2023 DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS Defence Therapeutics Inc.
10-Apr-2023 Evotec SE provides update on cyber attack Evotec SE
10-Apr-2023 Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med Sernova Corp.
10-Apr-2023 Mainz Biomed Provides Full Year 2022 Financial Results Mainz BioMed N.V.
07-Apr-2023 Cyber Attack on Evotec Evotec SE
06-Apr-2023 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill Vita 34 AG
06-Apr-2023 INNOVATIVE ACCESS DEAL SECURED IN THE UK FOR LYNPARZA (OLAPARIB) TO TREAT BRCA-MUTATED CANCERS AstraZeneca
06-Apr-2023 Solvay announces strategic collaboration with Ginkgo Bioworks and expands its R&I footprint in the United States Solvay
06-Apr-2023 WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System WuXi STA
06-Apr-2023 Gerresheimer AG: Gerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA Gerresheimer AG